AI
HRMY icon

AdvisorShares Investments’s Harmony Biosciences HRMY Stock Holding History

AdvisorShares Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,300
Closed -$498K – 299
2025
Q4 		$498K Buy
+13,300
New +$437K 0.08% 112

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AdvisorShares Investments's HRMY Position: Q1 2026 in Review

AdvisorShares Investments sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 13,300 shares — an estimated $498K sold.

AdvisorShares Investments first reported a position in HRMY in Q4 2025 and held it in 1 quarter. The position peaked at $498K in Q4 2025. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • AdvisorShares Investments reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • AdvisorShares Investments sold 13,300 Harmony Biosciences shares in Q1 2026, an estimated $498K.
  • AdvisorShares Investments first reported a position in Harmony Biosciences in Q4 2025 and held it in 1 quarter.
  • AdvisorShares Investments's Harmony Biosciences position peaked at $498K in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.